Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brock Schroeder

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|October 7, 2023
System dynamics simulation for evaluating implementation strategies of genomic sequencing: tutorial and conceptual modelHadi A Khorshidi, Deborah Marshall, Ilias Goranitis, et al.
Current Medical Research and Opinion|February 11, 2009
Patient characteristics, drug adherence patterns, and hypoglycemia costs for patients with type 2 diabetes mellitus newly initiated on exenatide or insulin glargineRosalind Fabunmi, Loretta L Nielsen, Ralph Quimbo, et al.
NPJ Breast Cancer|August 11, 2017
Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancerBrock Schroeder, Yi Zhang, Olle Stål, et al.
The American Journal of Managed Care|October 9, 2014
Health economic analysis of Breast Cancer Index in patients with ER+, LN- breast cancerGary Gustavsen, Brock Schroeder, Patrick Kennedy, et al.
Journal of the American Heart Association|June 14, 2022
Integrating a Polygenic Risk Score for Coronary Artery Disease as a Risk-Enhancing Factor in the Pooled Cohort Equation: A Cost-Effectiveness Analysis StudyDeo Mujwara, Geoffrey Henno, Stephen T Vernon, et al.
Pharmacoeconomics - Open|March 10, 2021
Economic Impact of Coverage Expansion for Non-invasive Prenatal Testing Through a Performance-Based Risk-Sharing AgreementTaryn A G Quinlan, Brock Schroeder, Sue Kwon, et al.
Breast Cancer Research and Treatment|November 19, 2015
Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancerTara Sanft, Bilge Aktas, Brock Schroeder, et al.
JCO Precision Oncology|May 16, 2024
Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non-Small Cell Lung CancerJeanna Wallenta Law, Bela Bapat, Connor Sweetnam, et al.
The Lancet. Oncology|September 17, 2013
Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study populationDennis C Sgroi, Ivana Sestak, Jack Cuzick, et al.
NPJ Genomic Medicine|March 28, 2024
Advancing access to genome sequencing for rare genetic disorders: recent progress and call to actionVaidehi Jobanputra, Brock Schroeder, Heidi L Rehm, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Review of Pharmacoeconomics & Outcomes Research|October 7, 2023
System dynamics simulation for evaluating implementation strategies of genomic sequencing: tutorial and conceptual modelHadi A Khorshidi, Deborah Marshall, Ilias Goranitis, et al.
Current Medical Research and Opinion|February 11, 2009
Patient characteristics, drug adherence patterns, and hypoglycemia costs for patients with type 2 diabetes mellitus newly initiated on exenatide or insulin glargineRosalind Fabunmi, Loretta L Nielsen, Ralph Quimbo, et al.
NPJ Breast Cancer|August 11, 2017
Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancerBrock Schroeder, Yi Zhang, Olle Stål, et al.
The American Journal of Managed Care|October 9, 2014
Health economic analysis of Breast Cancer Index in patients with ER+, LN- breast cancerGary Gustavsen, Brock Schroeder, Patrick Kennedy, et al.
Journal of the American Heart Association|June 14, 2022
Integrating a Polygenic Risk Score for Coronary Artery Disease as a Risk-Enhancing Factor in the Pooled Cohort Equation: A Cost-Effectiveness Analysis StudyDeo Mujwara, Geoffrey Henno, Stephen T Vernon, et al.
Pharmacoeconomics - Open|March 10, 2021
Economic Impact of Coverage Expansion for Non-invasive Prenatal Testing Through a Performance-Based Risk-Sharing AgreementTaryn A G Quinlan, Brock Schroeder, Sue Kwon, et al.
Breast Cancer Research and Treatment|November 19, 2015
Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancerTara Sanft, Bilge Aktas, Brock Schroeder, et al.
JCO Precision Oncology|May 16, 2024
Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non-Small Cell Lung CancerJeanna Wallenta Law, Bela Bapat, Connor Sweetnam, et al.
The Lancet. Oncology|September 17, 2013
Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study populationDennis C Sgroi, Ivana Sestak, Jack Cuzick, et al.
NPJ Genomic Medicine|March 28, 2024
Advancing access to genome sequencing for rare genetic disorders: recent progress and call to actionVaidehi Jobanputra, Brock Schroeder, Heidi L Rehm, et al.
Pageof 2